<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365094">
  <stage>Registered</stage>
  <submitdate>3/10/2013</submitdate>
  <approvaldate>11/10/2013</approvaldate>
  <actrnumber>ACTRN12613001140741</actrnumber>
  <trial_identification>
    <studytitle>A pilot study of the acceptability and practicability of breathing training as a therapeutic measure for psychogenic seizures</studytitle>
    <scientifictitle>Is breathing training control acceptable and practicable in patients with psychogenic seizures?</scientifictitle>
    <utrn>None</utrn>
    <trialacronym>None</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Psychogenic seizures</healthcondition>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Other mental health disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Breathing control training. 2  individual sessions of instruction by a respiratory physiotherapist, the first session of 60 minutes, the second session of 30 minutes one month later, with breathing exercises to carry at home, daily for 10 minutes for two months. Compliance will be recorded on seizure diaries.

</interventions>
    <comparator>Uncontrolled</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Acceptability of breathing control training (Linkert scale)
Adverse experiences (there are no known adverse experiences from breathing control training).</outcome>
      <timepoint>4 months </timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Proportion of patients free of psychogenic seizures according to patient account and seizure diary</outcome>
      <timepoint>4 months, 10 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Diagnosis of psychogenic seizures</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Serious respiratory disorder
Epilepsy</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>The trial is an assessment of tolerability and acceptability, and will generate outcome data on which to base a power calculation. All patients will have the intervention</concealment>
    <sequence>No randomisation</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods>Descriptive</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>2/12/2013</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate>1/12/2014</anticipatedenddate>
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Canterbury</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Christchurch Hospital</primarysponsorname>
    <primarysponsoraddress>Riccarton Avenue, Christchurch 8011</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>There is evidence that poor breathing control is implicated in triggering of psychogenic seizure. We hypothesize that improving breathing control will improve psychogenic seizures. We wish to carry out a preliminary uncontrolled trial in 20 patients to establish whether breathing control training is practicable and acceptable in patients with psychogenic seizures, and to have a preliminary estimate of efficacy to inform a power calculation. Patients will have two sessions of training, with exercises to do at home, within two months of recruitment. They will be reviewed clinically at 4 and 10 months. Acceptability of breathing control training and adverse experinces will be recorded only at 4 months.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>HDEC New Zealand</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>7/11/2013</ethicsubmitdate>
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Roderick Duncan</name>
      <address>Department of Neurology, Christchurch Hospital, Riccarton Avenue Christchurch 8011</address>
      <phone>+6433640640</phone>
      <fax />
      <email>roderick.duncan@cdhb.health.nz</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Roderick Duncan</name>
      <address>Department of Neurology, Christchurch Hospital, Riccarton Avenue Christchurch 8011</address>
      <phone>+6433640640</phone>
      <fax />
      <email>roderick.duncan@cdhb.health.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Roderick Duncan</name>
      <address>Department of Neurology, Christchurch Hospital, Riccarton Avenue Christchurch 8011</address>
      <phone>+6433640640</phone>
      <fax />
      <email>roderick.duncan@cdhb.health.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Roderick Duncan</name>
      <address>Department of Neurology, Christchurch Hospital, Riccarton Avenue Christchurch</address>
      <phone>+6433640640</phone>
      <fax />
      <email>roderick.duncan@cdhb.health.nz</email>
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>